Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824895) titled 'Mazdutide for Weight Management and Gout in Adults With Obesity' on Sept. 3.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Hongwei Jiang
Condition:
Gout
Obesity (BMI>30)
Hyperuricemia
Metabolic Syndrome
Intervention:
Drug: Mazdutide
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: September 15, 2026
Target Sample Size: 30
To know more, visit https://clinicaltrials.gov/study/NCT07824895
Disclaimer: Curated by HT Syndication....